Saturday, December 1, 2012

Health officials scale back efforts to identify new fungal meningitis cases


Related: Fungal meningitis patient's sickness started with a cure
The discovery of new cases in the fungal meningitis outbreak has slowed in Virginia, prompting state health officials to change the way they monitor those at risk for becoming ill.
This week, health officials will begin to reign in surveillance efforts aimed at identifying new cases in the outbreak, which was tied to tainted steroid injections and has killed 36 and sickened hundreds in 19 states. The change comes as data collected by the Virginia Department of Health show a 20-day average incubation period from when a person received the steroid injection and first developed symptoms of the fungal infection.
"We do expect that there may be additional cases, but in much smaller numbers and with a decreasing frequency," said Dr. David Trump, state epidemiologist for the health department. "Hopefully, everyone who was exposed knows what to look for and won't hesitate to seek medical attention."
In Virginia, only about 13 percent of people who received one of the recalled shots blamed in the outbreak developed a fungal infection.
But early in the outbreak, before officials knew the likelihood of developing an infection after receiving one of the shots, the state decided to take the rare — and time-intensive — step of calling anyone at risk of becoming ill.
Since October, health department nurses have made weekly calls to everyone who received one of the shots but had not yet had a lumbar puncture to test for meningitis.
In the Roanoke and Alleghany health districts, the process involved assigning about 25 employees to call about 260 people, said Dr. Stephanie Harper, director of the two districts.
"We directed a lot of resources to getting it done," she said. "It's manpower intensive."
The department also made home visits and sent certified letters to ensure that no person was missed, she said.
Many of those on the original list ended up being referred to the emergency rooms at Carilion Roanoke Memorial Hospital and LewisGale Medical Center for lumbar punctures, Harper said.
This week will mark the last time Harper's nurses make the weekly calls, she said. After that, her staff will be available to answer questions, but they will not actively check in with people, she said.
The decision follows the recommendation from Trump that the surveillance is no longer necessary, although he has left the ultimate decision up to the various health district directors in Southwest Virginia who have been coordinating the efforts.
So, for instance, the outreach will continue until Dec. 23 to the 94 affected people living in the New River Valley Health District, said Dr. Molly O'Dell, director of that district.
"We're considering going to once a month for three months after that," she said. "But we haven't decided."
Virginia identified 680 people who received a contaminated injection made by New England Compounding Center at one of two outpatient clinics in Southwest Virginia. In Virginia, most people received the shot at Insight Imaging in Roanoke, but 27 were exposed after getting an injection at New River Valley Surgery Center in Montgomery County.
O'Dell said none of the 51 cases identified in Virginia so far have involved patients who got the shot at the New River center.
The vast majority of people who developed meningitis began to have symptoms between the end of September and the middle of October, Trump said.
Source found here  

Subpoenas Handed Down In Meningitis Case


December 1, 2012 9:01 PM

FRAMINGHAM (CBS) – A federal grand jury has begun to hand down subpoenas in its investigation of the deadly meningitis outbreak linked to a Framingham pharmacy.

Continue reading here

California Bill Would Require Reporting of Prescription Drug Related Deaths to State's Medical Board


November 28, 2012 02:19 PM

Topics:
A bill that would require coroners in California to report all prescription drug related deaths to the Medical Board of California was introduced to the state Senate by Senator Curren D. Price, Jr (D-Los Angeles). The bill aims to help authorities identify physicians whose “prescribing practices may be harming patients,” reports the Los Angeles Times. A Los Angeles Times investigative report indicated that in four California counties 3,733 accidental deaths were related to prescription drugs, and that in almost half of those cases the individual had a prescription for at least one drug that caused the death. California law already requires that prescription drug related deaths suspected to be caused by “gross negligence” by a physician must be reported to the Medical Board. After considering the findings of investigative report, the Medical Board agreed that “all deaths related to prescription drug overdoses should be reported to the board for further investigation,” according to the Los Angeles Times.

Source found here

U.S. Attorney for S.D.N.Y. Files Complaint Against K-V Pharmaceutical Corporation Seeking Determination That Debts Are Not Dischargeable in Bankruptcy and Copy of Complaint


The United States Attorney for the Southern District of New York, Preet Bharara, filed an adversary complaint on behalf of the U.S. Government against K-V Pharmaceutical Corporation on Monday in the Southern District of New York Bankruptcy Court. The complaint seeks a judgement of the bankruptcy court (which is presiding over K-V Pharmaceutical Corporation’s chapter 11 case) that certain obligations owing to the government are not dischargeable in K-V Pharmaceutical’s bankruptcy pursuant to sections 523(a)(2), 523(a)(7) and 1141(d)(6) of the Bankruptcy Code.

Continue reading and view complaint here